PF
PFIZER INC
PFE Health Care · Pharmaceuticals & Biotechnology
Latest period 2026-06-28 · 38 filings on record
SHOWING
Trailing twelve months — each point sums the four quarters ending there.
Ranked against Health Care · 51 peers
Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-28.
Growth
12th pct
▲+8 over range · as of 2026-06-28
Revenue +2.6% YoY, earnings -108.5% YoY · sector avg 66
Quality
22nd pct
▼−4 over range · as of 2026-06-28
-1.6% net margin, 5% return on equity, 17% free-cash-flow margin, profitable in 6 of last 8 quarters · sector avg 45
Safety
21st pct
▼−23 over range · as of 2026-06-28
Net debt 4.6x EBITDA, 1.3x current ratio · sector avg 59
OVERVIEWvs prior TTM Δ
Trailing twelve months · ending 2026-06-28 · green = improving · click a row to chart it
Revenue $63.7B +0.6% Gross margin 73.2% −0.3pp Operating margin — — Net margin 6.8% −5.0pp Net income $4.3B −42.2%
Debt / equity
0.74
+3.7%
EPS (diluted)
—
—
EBITDA
—
—
Filings
Full history 7 match| Year | Q1 | Q2 | Q3 | FY |
|---|---|---|---|---|
| 2026 | 10-Q Q1 2026, clears this filter | 10-Q Q2 2026 | no filing | no filing |
| 2025 | 10-Q Q1 2025, clears this filter | 10-Q Q2 2025 | 10-Q Q3 2025 | 10-K FY 2025 |
| 2024 | 10-Q Q1 2024, clears this filter | 10-Q Q2 2024 | 10-Q Q3 2024 | 10-K FY 2024 |
| 2023 | 10-Q Q1 2023, clears this filter | 10-Q Q2 2023 | 10-Q Q3 2023 | 10-K FY 2023 |
| 2022 | 10-Q Q1 2022, clears this filter | 10-Q Q2 2022 | 10-Q Q3 2022 | 10-K FY 2022 |
| 2021 | 10-Q Q1 2021, clears this filter | 10-Q Q2 2021 | 10-Q Q3 2021 | 10-K FY 2021 |
| 2020 | 10-Q Q1 2020, clears this filter | 10-Q Q2 2020 | 10-Q Q3 2020 | 10-K FY 2020 |
| 2019 | no filing | no filing | 10-Q Q3 2019 | 10-K FY 2019 |
All 7 filings
10-Q Q1 2020 2020-05-07 Pro →Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans
Trends
Trailing twelve months, rolling one quarter at a time
Revenue
| Period | Period end | Revenue |
|---|---|---|
| TTM 19-12 | 2019-12-31 | $40.9B |
| TTM 20-03 | 2020-03-29 | $37.9B |
| TTM 20-06 | 2020-06-28 | $34.5B |
| TTM 20-09 | 2020-09-27 | $32.1B |
| TTM 20-12 | 2020-12-31 | $41.7B |
| TTM 21-04 | 2021-04-04 | $46.1B |
| TTM 21-07 | 2021-07-04 | $55.1B |
| TTM 21-10 | 2021-10-03 | $68.9B |
| TTM 21-12 | 2021-12-31 | $73.6B |
| TTM 22-04 | 2022-04-03 | $84.8B |
| TTM 22-07 | 2022-07-03 | $93.6B |
| TTM 22-10 | 2022-10-02 | $92.2B |
| TTM 22-12 | 2022-12-31 | $101.2B |
| TTM 23-04 | 2023-04-02 | $94.0B |
| TTM 23-07 | 2023-07-02 | $79.3B |
| TTM 23-10 | 2023-10-01 | $70.1B |
| TTM 23-12 | 2023-12-31 | $59.6B |
| TTM 24-03 | 2024-03-31 | $55.9B |
| TTM 24-06 | 2024-06-30 | $56.2B |
| TTM 24-09 | 2024-09-29 | $60.4B |
| TTM 24-12 | 2024-12-31 | $63.6B |
| TTM 25-03 | 2025-03-30 | $62.5B |
| TTM 25-06 | 2025-06-29 | $63.8B |
| TTM 25-09 | 2025-09-28 | $62.8B |
| TTM 25-12 | 2025-12-31 | $62.6B |
| TTM 26-03 | 2026-03-29 | $63.3B |
| TTM 26-06 | 2026-06-28 | $63.7B |
Net income
| Period | Period end | Net income |
|---|---|---|
| TTM 19-12 | 2019-12-31 | $16.0B |
| TTM 20-03 | 2020-03-29 | $15.5B |
| TTM 20-06 | 2020-06-28 | $13.9B |
| TTM 20-09 | 2020-09-27 | $7.7B |
| TTM 20-12 | 2020-12-31 | $9.2B |
| TTM 21-04 | 2021-04-04 | $10.7B |
| TTM 21-07 | 2021-07-04 | $12.8B |
| TTM 21-10 | 2021-10-03 | $19.4B |
| TTM 21-12 | 2021-12-31 | $22.0B |
| TTM 22-04 | 2022-04-03 | $25.0B |
| TTM 22-07 | 2022-07-03 | $29.3B |
| TTM 22-10 | 2022-10-02 | $29.8B |
| TTM 22-12 | 2022-12-31 | $31.4B |
| TTM 23-04 | 2023-04-02 | $29.1B |
| TTM 23-07 | 2023-07-02 | $21.5B |
| TTM 23-10 | 2023-10-01 | $10.5B |
| TTM 23-12 | 2023-12-31 | $2.1B |
| TTM 24-03 | 2024-03-31 | -$309.0M |
| TTM 24-06 | 2024-06-30 | -$2.6B |
| TTM 24-09 | 2024-09-29 | $4.3B |
| TTM 24-12 | 2024-12-31 | $8.0B |
| TTM 25-03 | 2025-03-30 | $7.9B |
| TTM 25-06 | 2025-06-29 | $10.8B |
| TTM 25-09 | 2025-09-28 | $9.8B |
| TTM 25-12 | 2025-12-31 | $7.8B |
| TTM 26-03 | 2026-03-29 | $7.5B |
| TTM 26-06 | 2026-06-28 | $4.3B |
ZOOM
TTM 19-12
TTM 26-06
Grade history
Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.
Growth
12
Quality
22
Safety
21
Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100
| Period | Period end | Growth | Quality | Safety |
|---|---|---|---|---|
| TTM 19-12 | 2019-12-31 | not scored | not scored | not scored |
| TTM 20-03 | 2020-03-29 | not scored | not scored | not scored |
| TTM 20-06 | 2020-06-28 | not scored | not scored | not scored |
| TTM 20-09 | 2020-09-27 | not scored | not scored | not scored |
| TTM 20-12 | 2020-12-31 | not scored | not scored | not scored |
| TTM 21-04 | 2021-04-04 | not scored | not scored | not scored |
| TTM 21-07 | 2021-07-04 | not scored | not scored | not scored |
| TTM 21-10 | 2021-10-03 | not scored | not scored | not scored |
| TTM 21-12 | 2021-12-31 | not scored | not scored | not scored |
| TTM 22-04 | 2022-04-03 | not scored | not scored | not scored |
| TTM 22-07 | 2022-07-03 | not scored | not scored | not scored |
| TTM 22-10 | 2022-10-02 | not scored | not scored | not scored |
| TTM 22-12 | 2022-12-31 | not scored | not scored | not scored |
| TTM 23-04 | 2023-04-02 | not scored | not scored | not scored |
| TTM 23-07 | 2023-07-02 | not scored | not scored | not scored |
| TTM 23-10 | 2023-10-01 | 4 | 26 | 44 |
| TTM 23-12 | 2023-12-31 | 3 | 11 | 4 |
| TTM 24-03 | 2024-03-31 | 9 | 33 | 9 |
| TTM 24-06 | 2024-06-30 | 17 | 14 | 3 |
| TTM 24-09 | 2024-09-29 | 94 | 41 | 11 |
| TTM 24-12 | 2024-12-31 | 92 | 29 | 26 |
| TTM 25-03 | 2025-03-30 | 22 | 44 | 25 |
| TTM 25-06 | 2025-06-29 | 87 | 46 | 23 |
| TTM 25-09 | 2025-09-28 | 13 | 43 | 22 |
| TTM 25-12 | 2025-12-31 | 4 | 23 | 19 |
| TTM 26-03 | 2026-03-29 | 30 | 40 | 19 |
| TTM 26-06 | 2026-06-28 | 12 | 22 | 21 |